Nordhealth AS - Invitation to Q4 2023 presentation
Nordhealth will report and present its Q4 2023 results on Tuesday the 5th of March 2024.
The results will be presented in a live presentation and subsequent Q&A session with CEO Charles MacBain and CFO Mari Orttenvuori on the 5th of March at 13:00 CET.
Please use the following link to attend: https://us02web.zoom.us/j/83057714357
The presentation will be recorded and made available on www.nordhealth.com. The presentation material for Q4/2023 and the 2H/2023 interim financial report will be available on 5 March 2024 at 07:30 am CET on www.newsweb.no and on Nordhealth's IR website https://nordhealth.com/investor/news-and-documents/
For further information, please contact:
Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200
Mari Orttenvuori, CFO mari.orttenvuori@nordhealth.com +358 46 8765 233
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 50,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries.
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with 400 employees working either remotely or from offices (collaboration hubs). Visit the company’s website at nordhealth.com.